- Home
- ZBAO vs KZR Comparison
ZBAO vs KZR Comparison
Compare ZBAO & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAO
- KZR
- Stock Information
- Founded
- ZBAO 2015
- KZR 2015
- Country
- ZBAO China
- KZR United States
- Employees
- ZBAO N/A
- KZR N/A
- Industry
- ZBAO
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- ZBAO
- KZR Health Care
- Exchange
- ZBAO NYSE
- KZR Nasdaq
- Market Cap
- ZBAO 48.7M
- KZR 44.1M
- IPO Year
- ZBAO 2024
- KZR 2018
- Fundamental
- Price
- ZBAO $1.14
- KZR $4.60
- Analyst Decision
- ZBAO
- KZR Hold
- Analyst Count
- ZBAO 0
- KZR 2
- Target Price
- ZBAO N/A
- KZR $9.00
- AVG Volume (30 Days)
- ZBAO 20.5K
- KZR 24.2K
- Earning Date
- ZBAO 11-04-2024
- KZR 05-08-2025
- Dividend Yield
- ZBAO N/A
- KZR N/A
- EPS Growth
- ZBAO N/A
- KZR N/A
- EPS
- ZBAO 0.06
- KZR N/A
- Revenue
- ZBAO $25,274,784.00
- KZR N/A
- Revenue This Year
- ZBAO $65.08
- KZR N/A
- Revenue Next Year
- ZBAO $34.27
- KZR N/A
- P/E Ratio
- ZBAO $19.48
- KZR N/A
- Revenue Growth
- ZBAO 29.25
- KZR N/A
- 52 Week Low
- ZBAO $1.06
- KZR $4.36
- 52 Week High
- ZBAO $5.70
- KZR $9.20
- Technical
- Relative Strength Index (RSI)
- ZBAO N/A
- KZR 29.20
- Support Level
- ZBAO N/A
- KZR $4.36
- Resistance Level
- ZBAO N/A
- KZR $6.37
- Average True Range (ATR)
- ZBAO 0.00
- KZR 0.34
- MACD
- ZBAO 0.00
- KZR -0.12
- Stochastic Oscillator
- ZBAO 0.00
- KZR 11.94
Stock Price Comparison Chart: ZBAO vs KZR
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.